二次医療における"緑の"吸入器の処方に対する処方者の態度
Aazaz Rehman1, Joseph Marchant1, Jiakun Yu2
1Respiratory Medicine, University Hospitals Sussex, Brighton, GBR.
Cureus
|September 2, 2025
まとめ
医療従事者は排出量を減らしたいが 吸入器のカーボンフットプリントに気づいていない 知識と信頼の欠如は,測定用量吸入器 (MDIs) から低炭素乾燥粉末吸入器 (DPIs) に移行することを妨げ,持続可能性の努力を制限しています.
科学分野:
- 環境科学
- 医療の持続可能性
- 呼吸器医学
背景:
- 保健医療は世界の温室効果ガス (GHG) 排出に大きく貢献しています.
- 測定用量吸入器 (MDIs) は,ドライパウダー吸入器 (DPIs) よりも高い炭素排出量を持っています.
- 適格性にもかかわらず,多くの患者は高炭素のMDIを継続しており,持続可能な処方慣行におけるギャップを示しています.
研究 の 目的:
- 介護医療従事者 (HCP) が患者をMDIからDPIに切り替えるときに直面する障壁を特定する.
- 持続的な吸入器の処方に関する医療従事者の認識と経験を理解する.
- 低炭素吸入器の選択を促進する現在の持続可能性の取り組みの有効性を評価する.
主な方法:
- 19人の介護医療従事者との半構造面接による定性研究
- 参加者の視点の多様性を確保するために目的のあるサンプリングを使用します.
- フレームワーク法とNVivoソフトウェアを用いたインタビューのトランスクリプトのテーマ分析
主要な成果:
- 適切な吸入器の認識,知識のギャップ,処方に対する知覚の影響という 3つの主要なテーマが浮上しました.
- 医療従事者は医療のカーボンフットプリントを減らしたいと願った.
- 吸入器のカーボンフットプリントに関する認識の欠如と知識/信頼の欠如は,DPIの処方に重大な障壁であった.
結論:
- インハラ剤の処方に関する現在の持続可能性の取り組みは 意図した効果を上げていません
- 持続的な吸入器の選択への障壁を克服するには,意識と教育の向上が不可欠です.
- DPIのような低炭素吸入器の採用を促進するには,知識のギャップを解決し,医療従事者の信頼を高めることが不可欠です.
関連する概念動画
Inhaled Medications
388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388
COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
575
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
575
Antiasthma Drugs: β2-Adrenoceptor Agonists
377
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
377
Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K


